APA (7th ed.) Citation

Liu, J., Tian, J., Wang, Z., Wang, L., Huang, C., Zhou, J., . . . Zheng, W. (2022). Secukinumab in the treatment of parenchymal neuro-Behçet’s syndrome. Rheumatology (Oxford, England), 61(9), e277-e279. https://doi.org/10.1093/rheumatology/keac222

Chicago Style (17th ed.) Citation

Liu, Jinjing, Jimei Tian, Zhimian Wang, Li Wang, Can Huang, Jiaxin Zhou, Xiaofeng Zeng, Yan Zhao, and Wenjie Zheng. "Secukinumab in the Treatment of Parenchymal Neuro-Behçet’s Syndrome." Rheumatology (Oxford, England) 61, no. 9 (2022): e277-e279. https://doi.org/10.1093/rheumatology/keac222.

MLA (9th ed.) Citation

Liu, Jinjing, et al. "Secukinumab in the Treatment of Parenchymal Neuro-Behçet’s Syndrome." Rheumatology (Oxford, England), vol. 61, no. 9, 2022, pp. e277-e279, https://doi.org/10.1093/rheumatology/keac222.